Accriva Diagnostics, Inc. recalls Hemochron Jr.
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Microcoagulation test used to evaluate low dose heparin anticoagulation has a mispositioned or absent clot activating reagent, which may result in out-of-range high error code, or erroneously high results, which may lead retest, or overestimation of patient's anticoagulation, leading to inadequate anticoagulant therapy, which could result in thrombosis.
- Products
-
- Hemochron Jr.
- Company
- Accriva Diagnostics, Inc.
- Where it was sold
-
Worldwide - US Nationwide distribution in the states of MA, MO, AK, WV, NJ, TX, VA, IL, NY and the countries of China, Colombia.
States: Alaska, Illinois, Massachusetts, Missouri, New Jersey, New York, Texas, Virginia, West Virginia
- Barcodes
10711234103012- Units affected
- 28710
- About this recall
- Hemochron Jr., Whole Blood Microcoagulation System, Activated Partial Thromboplastin Time (APTT) Test Cuvette, REF: J103